1. Home
  2. BHF vs AMRX Comparison

BHF vs AMRX Comparison

Compare BHF & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brighthouse Financial Inc.

BHF

Brighthouse Financial Inc.

HOLD

Current Price

$62.61

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$12.82

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHF
AMRX
Founded
2016
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.7B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
BHF
AMRX
Price
$62.61
$12.82
Analyst Decision
Hold
Strong Buy
Analyst Count
8
5
Target Price
$57.71
$15.60
AVG Volume (30 Days)
405.5K
1.4M
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
157.89
EPS
N/A
0.22
Revenue
N/A
N/A
Revenue This Year
$27.10
$4.48
Revenue Next Year
$1.09
$7.13
P/E Ratio
$4.34
$58.41
Revenue Growth
N/A
N/A
52 Week Low
$43.16
$7.02
52 Week High
$66.33
$15.42

Technical Indicators

Market Signals
Indicator
BHF
AMRX
Relative Strength Index (RSI) 65.41 50.14
Support Level $59.04 $12.45
Resistance Level $62.63 $12.85
Average True Range (ATR) 0.54 0.48
MACD 0.06 -0.00
Stochastic Oscillator 94.13 29.84

Price Performance

Historical Comparison
BHF
AMRX

About BHF Brighthouse Financial Inc.

Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, Run-off and Corporate and Other. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked, and income annuities. The life segment includes variable, term, universal, and whole life policies.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: